NCT00212355View on ClinicalTrials.gov

Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.

PHASE3CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

April 30, 2008

Study Completion Date

January 31, 2009

Conditions
Wilson's Disease
Interventions
DRUG

NPC-02

zinc acetate

Sponsors

Lead Sponsor

Nobelpharma
All Listed Sponsors
lead

Nobelpharma

INDUSTRY

NCT00212355 - Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan. | Biotech Hunter | Biotech Hunter